Grants and Contributions:
Title:
Development of Novel Chicken antibody Platform for Therapeutic Purposes
Agreement Number:
942027
Agreement Value:
$418,486.00
Agreement Date:
Jan 22, 2020 - Feb 28, 2022
Description:
Somru BioScience Inc. intends to develop fully integrated therapeutic antibody discovery platform that allows us to unlock complex targets and enable discovery of novel and rare antibodies with therapeutic potential.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Charlottetown, Prince Edward Island, CA C1E 0B7
Reference Number:
172-2019-2020-Q4-942027
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
806733887
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 59 days.
Amendment Date
Jan 28, 2022
Recipient's Legal Name:
Somru BioScience Inc.
Federal Riding Name:
Charlottetown
Federal Riding Number:
11002
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710
Amendments: